研究者詳細 - 中嶋　正太郎

論文 - 中嶋　正太郎

分割表示74 件中 41 - 60 件目／全件表示 >>

The effects of T-DXd on the expression of HLA class I and chemokines CXCL9/10/11 in HER2-overexpressing gastric cancer cells.

Nakajima S, Mimura K, Matsumoto T, Thar Min AK, Ito M, Nakano H, Neupane P, Kanke Y, Okayama H, Saito M, Momma T, Watanabe Y, Hanayama H, Hayase S, Saze Z, Kono K

Scientific reports 11 ( 1 ) 16891 - 16891 2021年8月

Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer.

Petersen SH, Kua LF, Nakajima S, Yong WP, Kono K.

Scientific Reports 11 ( 1 ) 12264 - 12264 2021年6月

Stromal expression of cancer-associated fibroblast-related molecules, versican and lumican, is strongly associated with worse relapse-free and overall survival times in patients with esophageal squamous cell carcinoma.

Yamauchi N, Kanke Y, Saito K, Okayama H, Yamada S, Nakajima S, Endo E, Kase K, Yamada L, Nakano H, Matsumoto T, Hanayama H, Watanabe Y, Hayase S, Saito M, Saze Z, Mimura K, Momma T, Oki S, Hashimoto Y, Kono K

Oncology letters 21 ( 6 ) 445 - 445 2021年6月（ ISSN:1792-1074 ）

Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.

Nakajima S, Mimura K, Saito K, Thar Min AK, Endo E, Yamada L, Kase K, Yamauchi N, Matsumoto T, Nakano H, Kanke Y, Okayama H, Saito M, Neupane P, Saze Z, Watanabe Y, Hanayama H, Hayase S, Kaneta A, Momma T, Ohki S, Ohira H, Kono K

Molecular cancer research : MCR 19 ( 6 ) 1085 - 1095 2021年6月（ ISSN:1541-7786 ）

ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.

Kase K, Saito M, Nakajima S, Takayanagi D, Saito K, Yamada L, Ashizawa M, Nakano H, Hanayama H, Onozawa H, Okayama H, Endo H, Fujita S, Sakamoto W, Saze Z, Momma T, Mimura K, Ohki S, Shiraishi K, Kohno T, Kono K

Carcinogenesis 42 ( 1 ) 21 - 30 2021年2月（ ISSN:0143-3334 ）

Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.

Min AKT, Mimura K, Nakajima S, Okayama H, Saito K, Sakamoto W, Fujita S, Endo H, Saito M, Saze Z, Momma T, Ohki S, Kono K

Cancer immunology, immunotherapy : CII 70 ( 2 ) 289 - 298 2021年2月（ ISSN:0340-7004 ）

PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms.

Nakano H, Saito M, Nakajima S, Saito K, Nakayama Y, Kase K, Yamada L, Kanke Y, Hanayama H, Onozawa H, Okayama H, Fujita S, Sakamoto W, Saze Z, Momma T, Mimura K, Ohki S, Goto A, Kono K

Scientific reports 11 ( 1 ) 1982 - 1982 2021年1月

Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer.

Yamada L, Saito M, Thar Min AK, Saito K, Ashizawa M, Kase K, Nakajima S, Onozawa H, Okayama H, Endo H, Fujita S, Sakamoto W, Saze Z, Momma T, Mimura K, Ohki S, Kono K

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 24 ( 1 ) 60 - 71 2021年1月（ ISSN:1436-3291 ）

ARID1A欠損胃癌における合成致死に基づいたEZH2阻害剤の選択的感受性(Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer)

Yamada Leo, Saito Motonobu, Aung Kyi Thar Min , Saito Katsuharu, Ashizawa Mai, Kase Koji, Nakajima Shotaro, Onozawa Hisashi, Okayama Hirokazu, Endo Hisahito, Fujita Shotaro, Sakamoto Wataru, Saze Zenichiro, Momma Tomoyuki, Mimura Kosaku, Ohki Shinji, Kono Koji

Gastric Cancer 24 ( 1 ) 60 - 71 2021年1月（ ISSN:1436-3291 ）

Activation of the reward system ameliorates passive cutaneous anaphylactic reaction in mice.

Nakajima S, Manita S, Yu G, Ishimaru K, Kono K, Kitamura K, Nakao A

Allergy 75 ( 12 ) 3275 - 3279 2020年12月（ ISSN:0105-4538 ）

Tn Antigen Expression Defines an Immune Cold Subset of Mismatch-Repair Deficient Colorectal Cancer.

Matsumoto T, Okayama H, Nakajima S, Saito K, Nakano H, Endo E, Kase K, Ito M, Yamauchi N, Yamada L, Kanke Y, Onozawa H, Fujita S, Sakamoto W, Saito M, Saze Z, Momma T, Mimura K, Kono K

International journal of molecular sciences 21 ( 23 ) 9081 - 9081 2020年11月（ ISSN:16616596 ）

A TGFβ-Dependent Stromal Subset Underlies Immune Checkpoint Inhibitor Efficacy in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer.

Endo E, Okayama H, Saito K, Nakajima S, Yamada L, Ujiie D, Kase K, Fujita S, Endo H, Sakamoto W, Saito M, Saze Z, Momma T, Ohki S, Mimura K, Kono K

Molecular cancer research : MCR 18 ( 9 ) 1402 - 1413 2020年9月（ ISSN:1541-7786 ）

Current status of immune checkpoint inhibitors for gastric cancer.

Kono K, Nakajima S, Mimura K

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 23 ( 4 ) 565 - 578 2020年7月（ ISSN:1436-3291 ）

Current status of immune checkpoint inhibitors for gastric cancer(和訳中)

Kono Koji, Nakajima Shotaro, Mimura Kosaku

Gastric Cancer 23 ( 4 ) 565 - 578 2020年7月（ ISSN:1436-3291 ）

cutting-edge medicineがん診療の副作用マネジメント　複合がん免疫療法の発展を目指して

中嶋正太郎, 河野浩二

Precision Medicine 3 ( 4 ) 299 - 302 2020年4月（ ISSN:2434-3625 ）

巻頭グラビア複合がん免疫療法の発展を目指して

中嶋正太郎, 河野浩二

プレシジョンメディシン 2020年4月号 ( 4 ) 1 - 4 2020年3月

Changes in the mental health status of adolescents following the Fukushima Daiichi nuclear accident and related factors: Fukushima Health Management Survey.

Hayashi F, Sanpei M, Ohira T, Nakano H, Okazaki K, Yasumura S, Nakajima S, Yabe H, Suzuki Y, Kamiya K, Fukushima Health Management Survey Group

Journal of affective disorders 260 432 - 439 2020年1月（ ISSN:0165-0327 ）

第10 章腫瘍免疫学と移植免疫学がん細胞と正常非自己細胞に対する免疫応答

中尾篤人，井上修，氏家大輔，内田萌菜，柏木麻里子，香山尚子，河合利尚，木村元子，河野浩二，佐藤卓哉，竹田潔，中嶋正太郎，中野信浩，中山俊憲，中山勝文，廣瀬晃一，穂積勝人，村上正晃，村上悠二，八木良二，松嶋綱治，山田幸宏

基礎免疫学原著第6 版免疫系の機能とその異常 185 - 205 2020年

The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock.

Ishimaru K, Nakajima S, Yu G, Nakamura Y, Nakao A

International journal of molecular sciences 20 ( 24 ) 2019年12月（ ISSN:16616596 ）

Resveratrol inhibits IL-33-mediated mast cell activation by targeting the MK2/3-PI3K/Akt axis.

Nakajima S, Ishimaru K, Kobayashi A, Yu G, Nakamura Y, Oh-Oka K, Suzuki-Inoue K, Kono K, Nakao A

Scientific reports 9 ( 1 ) 18423 2019年12月

　前のページ - 次のページ　

<中嶋 正太郎>

論文 - 中嶋 正太郎

<中嶋　正太郎>

論文 - 中嶋　正太郎